Traws Pharma, Inc. (TRAW) Total Assets by Year
Traws Pharma, Inc. closed fiscal year 2025 with $10.6M in total assets, $11.2M in total liabilities and -$629K in shareholder equity. This represents a decrease of 57.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Traws Pharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TRAW Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.6M-57.5% | $25.0M+10.0% | $22.7M-42.4% | $39.4M-29.0% | $55.5M+177.6% | $20.0M-15.6% | $23.7M+32.1% | $17.9M+260.0% | $5.0M-78.6% | $23.2M-0.9% | $23.4M-50.5% | $47.3M-55.0% | $105.2M+25.4% | $83.9M | N/A |
| Total Liabilities | $11.2M-80.1% | $56.6M+371.2% | $12.0M+8.6% | $11.1M+18.2% | $9.4M-32.2% | $13.8M+14.1% | $12.1M-3.5% | $12.5M-20.9% | $15.8M-12.5% | $18.1M+43.6% | $12.6M-46.8% | $23.7M-2.2% | $24.3M-90.0% | $242.2M | N/A |
| Total Equity | -$629K+98.0% | -$31.6M-396.4% | $10.7M-62.3% | $28.3M-38.6% | $46.1M+646.9% | $6.2M-46.6% | $11.6M+114.9% | $5.4M+146.1% | -$11.7M-372.1% | $4.3M-57.1% | $10.0M-56.0% | $22.7M-71.7% | $80.4M+150.8% | -$158.3M-14.4% | -$138.4M |
TRAW Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.5M-26.6% | $8.2M-57.2% | $10.6M-57.5% | $12.4M+39.2% | $15.6M-16.4% | $19.1M+4.9% | $25.0M+10.0% | $8.9M-67.0% | $18.7M-38.7% | $18.2M-48.2% | $22.7M-42.4% | $27.0M-38.2% |
| Total Liabilities | $9.8M+32.9% | $13.5M+3.1% | $11.2M-80.1% | $7.9M-28.0% | $7.4M-94.1% | $13.1M+7.5% | $56.6M+371.2% | $11.0M-12.4% | $124.2M+973.5% | $12.2M-0.2% | $12.0M+8.6% | $12.5M+20.3% |
| Total Equity | $1.7M-79.5% | -$5.3M-188.5% | -$629K+98.0% | $4.5M+323.6% | $8.3M+107.8% | $6.0M-0.2% | -$31.6M-396.4% | -$2.0M-114.0% | -$105.5M-658.4% | $6.0M-73.7% | $10.7M-62.3% | $14.5M-56.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Traws Pharma, Inc. financials
Frequently Asked Questions
What was Traws Pharma, Inc.'s total assets in fiscal year 2025?
Traws Pharma, Inc. closed fiscal year 2025 with $10.6M in total assets, $11.2M in total liabilities and -$629K in shareholder equity.
How fast is Traws Pharma, Inc.'s total assets growing?
Traws Pharma, Inc. (TRAW) total assets fell by 57.5% year over year, from $25.0M to $10.6M in fiscal year 2025.
What was Traws Pharma, Inc.'s total assets in the most recent quarter?
Traws Pharma, Inc. (TRAW) reported $11.5M in total assets in Q2 2026. This represents a decrease of 26.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Traws Pharma, Inc. (TRAW) reported on that line in every period on record.